MEPROBAMATE 400 MG TABLET

Meprobamate
$5.7486per EA
DEA Schedule CIV

Strength

400 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097097507

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MEPROBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040797

On Market Since

6/7/2021

Price History

1W

0.0%

1M

+0.3%

3M

-3.1%

6M

-5.0%

1Y

+3.2%

3Y

+13.3%

5Y

N/A

All

+13.3%

Related Drugs

Same classification

No related drugs found.